Shanghai Kaibao Pharmaceutical

SHE:300039 China Drug Manufacturers - Specialty & Generic
Market Cap
$892.43 Million
CN¥6.55 Billion CNY
Market Cap Rank
#9966 Global
#2129 in China
Share Price
CN¥6.26
Change (1 day)
-1.57%
52-Week Range
CN¥5.69 - CN¥6.96
All Time High
CN¥12.44
About

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and… Read more

Shanghai Kaibao Pharmaceutical - Asset Resilience Ratio

Latest as of September 2025: 17.36%

Shanghai Kaibao Pharmaceutical (300039) has an Asset Resilience Ratio of 17.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥860.80 Million
Cash + Short-term Investments
Total Assets
CN¥4.96 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Shanghai Kaibao Pharmaceutical's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Kaibao Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥860.80 Million 17.36%
Total Liquid Assets CN¥860.80 Million 17.36%

Asset Resilience Insights

  • Good Liquidity Position: Shanghai Kaibao Pharmaceutical maintains a healthy 17.36% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Kaibao Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Shanghai Kaibao Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Shanghai Kaibao Pharmaceutical (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Kaibao Pharmaceutical.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 3.98% CN¥180.02 Million CN¥4.52 Billion +0.71pp
2023-12-31 3.28% CN¥150.01 Million CN¥4.58 Billion +0.08pp
2022-12-31 3.19% CN¥136.07 Million CN¥4.26 Billion +1.67pp
2021-12-31 1.53% CN¥51.26 Million CN¥3.36 Billion -2.46pp
2020-12-31 3.98% CN¥114.65 Million CN¥2.88 Billion -13.10pp
2019-12-31 17.08% CN¥485.57 Million CN¥2.84 Billion +14.01pp
2018-12-31 3.07% CN¥84.28 Million CN¥2.75 Billion -0.79pp
2017-12-31 3.86% CN¥103.38 Million CN¥2.68 Billion +2.21pp
2016-12-31 1.64% CN¥41.58 Million CN¥2.53 Billion +0.67pp
2015-12-31 0.98% CN¥23.72 Million CN¥2.43 Billion -8.00pp
2014-12-31 8.97% CN¥190.00 Million CN¥2.12 Billion --
pp = percentage points